Login / Signup

Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.

Kyung Chul SonHo Seok ChungSeung Il JungMyung Soo KimEu Chang HwangJin-Woong KimDong Deuk Kwon
Published in: Journal of Korean medical science (2018)
Addition of amikacin to ciprofloxacin prophylaxis could not reduce infectious complications in patients with FQ-resistant rectal flora. Despite the amikacin sensitivity of infectious complications, single-dose amikacin addition to ciprofloxacin prophylaxis has limitations.
Keyphrases
  • pseudomonas aeruginosa
  • prostate cancer
  • risk factors
  • rectal cancer
  • cystic fibrosis
  • clinical trial
  • study protocol
  • phase iii
  • fine needle aspiration